Trademarkia Logo

Canada

C$
LEOVYLAS
REGISTERED

on 10 Nov 2023

Last Applicant/ Owned by

GLAXO GROUP LIMITED

GSK Medicines Research CentreGunnels Wood Road, Stevenage SG1 2NY

GB

Serial Number

2073520 filed on 28th Oct 2020

Registration Number

TMA1208261 registered on 10th Nov 2023

Registration expiry Date

28th Oct 2030

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

LEOVYLAS

Trademark usage description

pharmaceutical and medicinal preparations and substances for the treatment of oncological diseases and disorders, respiratory disease, viral diseases Read More

Classification Information


Class [005]
Pharmaceutical and medicinal preparations and substances for the treatment of oncological diseases and disorders, respiratory disease, viral diseases and disorders, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), influenza, measles, mumps, chickenpox, and bronchitis, immuno inflammatory diseases and disorders, namely, of autoimmune diseases and disorders, none of the aforementioned for the treatment of skin and skin disorders; vaccines for human use.


Classification kind code

11

Mark Details


Serial Number

2073520

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 12th Apr 2022
Search Recorded
Submitted for opposition 256
on 28th Oct 2021
Notification of Possible Opposition Sent
Submitted for opposition 234
on 2th Apr 2021
Partial Ceasing of Effect Received - No Amendments Required
Submitted for opposition 254
on 17th Feb 2021
Partial Cancellation Received - No Amendment Recorded
Submitted for opposition 231
on 8th Feb 2021
Limitation
Submitted for opposition 257
on 24th Dec 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 23rd Dec 2020
Formalized
Submitted for opposition 1
on 23rd Dec 2020
Created
Submitted for opposition 228
on 28th Oct 2020
International Registration
Submitted for opposition 30
on 28th Oct 2020
Filed